Australian Clinical Labs Ltd 2021 SR
The report is the inaugural ESG Statement for Australian Clinical Labs Limited (ACL), detailing its sustainability strategy and performance for the 2021 fiscal year. A major highlight was the company's agile response to the COVID-19 pandemic, which included performing over 1.7 million tests and employing 400 new staff. The company aligned its reporting with nine UN Sustainable Development Goals and the SASB framework. ACL committed to measuring its carbon footprint in 2022 and established a target of 40% female representation for its Board and senior management. Furthermore, the report emphasizes ACL's dedication to clinical excellence, medical research, and the training of future pathologists.
Company: Australian Clinical Labs Ltd
Sector: Health Care
Country: Australia
Year: 2021
Type: SR
Pages: 22
Australian Clinical Labs Ltd
The report is the inaugural ESG Statement for Australian Clinical Labs Limited (ACL), detailing its sustainability strategy and performance for the 2021 fiscal year. A major highlight was the company's agile response to the COVID-19 pandemic, which included performing over 1.7 million tests and employing 400 new staff. The company aligned its reporting with nine UN Sustainable Development Goals and the SASB framework. ACL committed to measuring its carbon footprint in 2022 and established a target of 40% female representation for its Board and senior management. Furthermore, the report emphasizes ACL's dedication to clinical excellence, medical research, and the training of future pathologists.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2021
Reporting Period
Jul 1, 2020 - Jun 30, 2021
Fiscal Year
2021
Published
Aug 1, 2021
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Sustainable Development Goals
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees